Lichen Sclerosus is not a rare condition despite being classified as such for decades
We are a team of health experts dedicated to providing advanced dermatological care for patients with mucocutaneous autoimmune disorder, with a special focus on Lichen Sclerosus (LS). Our team composes of some of the world’s leading doctors, scientists and patient advocates. We are committed to improving patient outcomes by offering the most effective treatment methods and technologies available in our field.
We have long been committed to uncovering the mechanisms underlying mucocutaneous autoimmune disorder. Our focus is on studying the etiology, pathogenesis, genetics, molecular biology, immunology and therapeutics of LS.
Find a cure for Lichen Sclerosus and give lives back to millions of women
We have conducted extensive research into LS pathogenesis. We identified biomarkers which play an important role in LS pathogenesis. This helped us determine effective therapeutic agents for LS.
Based on our extensive research, we developed DermGreen®, a highly effective, natural plant-based supplement, designed to cure LS and prevent the development of LS-associated carcinogenesis.
LS is a painful chronic progressive inflammatory dermatologic condition. It can affect any part of the skin, but it most frequently occurs in the anogenital area. It mostly affects the vulva or outer lips and surrounding area of the vagina as well as skin around the rectum.
LS affects women of all ages, particularly postmenopausal women, and often goes unrecognized and underreported. LS pathogenesis may be associated with autoimmune diseases, infections and genetic predisposition. LS isn’t contagious and can’t be spread through sexual contact.
Copyright © 2023 LS BioScience
